companydata.dkcompanydata.dk

Abbott Rapid Diagnostics A/S: Financial statements 2015

CVR: 24204650

Source: annual report 2015, Danish Business Authority

01/01/2015 – 31/12/2015

Abbott Rapid Diagnostics A/S (CVR 24204650) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 23,434,422 and a net result of DKK 4,079,241 compared with DKK -2,836,348 the year before. That is an increase of 17.2% compared with the year before. Equity in the 2015 report amounted to DKK 23,838,456. The solvency ratio was 60.2%. The company had 22 employees in the financial year.

Gross Profit
DKK 23,434,422
Profit/Loss
DKK 4,079,241
Equity
DKK 23,838,456
Total Assets
DKK 39,609,754
Employees
22

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015-23.4 mio.4.1 mio.23.8 mio.22
2014-20 mio.-2.8 mio.19.8 mio.27
2013-19.4 mio.-1.8 mio.-3.6 mio.26
201232 mio.7.6 mio.1.8 mio.-1.4 mio.9

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Abbott Rapid Diagnostics A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

Abbott Rapid Diagnostics A/S: The 2014 annual report is outJun 1, 2015

Abbott Rapid Diagnostics A/S has published its annual report for 2014. Gross profit came to DKK 19,999,260, and the net result was DKK -2,836,348.

Véronique Yvonne Ameye leaves the board of Abbott Rapid Diagnostics A/SFeb 28, 2015

As of February 28, 2015, Véronique Yvonne Ameye has left the board of directors of Abbott Rapid Diagnostics A/S.

About Abbott Rapid Diagnostics A/S

Abbott Rapid Diagnostics A/S is a Danish company of the type Aktieselskab based in København S, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ALERE A/S and MEDINOR A/S. The management consists of Berit Landsend-Holo. The board consists of Fredrik Björn Anders Björnulfson (chair), Berit Landsend-Holo and Mark Andrew Koewler. The company is owned by St. Jude Medical International Holding. The company has 18 employees (2018). In 2025, the company reported a gross profit of DKK 2,286,557 and a net result of DKK 561,997 compared with DKK 854,423 the year before. Equity in the 2025 report amounted to DKK 32,222,511.

Source: annual report 2025, Danish Business Authority